![Christopher Twitty](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Twitty
Directeur Technique/Scientifique/R&D chez
SKYE BIOSCIENCE, INC.
Fortune : 46 145 $ au 31/07/2026
Profil
Christopher G.
Twitty is Chief Scientific Officer at Skye Bioscience, Inc. since 2022.
Formerly, Dr. Twitty was Independent Director at Larkspur Health Acquisition Corp., Chief Scientific Officer, Head-R&D at OncoSec Medical, Inc. from 2017 to 2021, and Chief Scientific Officer at Onchilles Pharma, Inc. from 2021 to 2022.
Education includes a doctorate from Oregon Health & Science University and an undergraduate degree from San Diego State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SKYE BIOSCIENCE, INC. 0,23 % | 31/03/2026 | 81 242 ( 0,23 % ) | 46 145 $ | 31/07/2026 |
Postes actifs de Christopher Twitty
| Sociétés | Poste | Début |
|---|---|---|
| SKYE BIOSCIENCE, INC. | Directeur Technique/Scientifique/R&D | 13/12/2022 |
Anciens postes connus de Christopher Twitty
| Sociétés | Poste | Fin |
|---|---|---|
Onchilles Pharma, Inc.
 Onchilles Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery and development company | Directeur Technique/Scientifique/R&D | 01/12/2022 |
| ONCOSEC MEDICAL INCORPORATED | Directeur Technique/Scientifique/R&D | 20/10/2021 |
| LARR HEALPAR | Directeur/Membre du Conseil | - |
Formation de Christopher Twitty
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
41
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
OncoSec Medical, Inc.
 OncoSec Medical, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel immunotherapeutic products for immuno-oncology treatment | Health Technology |
San Diego State University
 San Diego State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oregon Health & Science University
 Oregon Health & Science University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Skye Bioscience, Inc.
 Skye Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets cannabinoid derivatives to treat ophthalmic disorders | Health Technology |
Onchilles Pharma, Inc.
Onchilles Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery and development company | Commercial Services |
Larkspur Health Acquisition Corp.
 Larkspur Health Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
